Navigation Links
LifeNet Health Chief Scientific Officer Wins Award
Date:5/8/2008

VIRGINIA BEACH, Va., May 8 /PRNewswire-USNewswire/ -- LifeNet Health, a leading allograft bio-implant company announces that Lloyd Wolfinbarger, Jr., Ph.D., was awarded an Excellence in Innovation award at the 11th Annual Hampton Roads Technology Council's Tech Nite in Hampton, Virginia.

The Excellence in Innovation award, sponsored by Willcox and Savage, P.C., recognizes the most innovative patents that were filed from within the Hampton Roads region. Hampton Roads Technology Council considered approximately 170 patents and three winners were chosen out of 10 nominees. The awards were issued to Hampton Roads inventors that were deemed by a panel of experts to represent significant commercial potential and/or social benefit.

Dr. Wolfinbarger was awarded the Excellence in Innovation award for a patent on Bioreactor Mediated Recellularization of Natural and Tissue Engineered Vascular Grafts.

"We are honored to have Dr. Wolfinbarger leading our research efforts at LifeNet Health. His contributions to the tissue banking industry are helping to restore health to thousands of patients. Since LifeNet Health's beginning 25 years Dr. Wolfinbarger has played an integral part in our company's success. He is a leader in medicine and we're proud that the Hampton Roads Technology Council recognized his valuable contributions at Tech Nite," states Rony Thomas, LifeNet Health's CEO.

Tech Nite is an annual recognition event, organized by the Hampton Roads Technology Council, for high-tech companies, individuals, entrepreneurs, and innovations of the Hampton Roads region. The Hampton Roads Technology Council's (http://www.hrtc.org) mission is to accelerate the transformation of Hampton Roads and its technology firms into world-recognized technology leaders.

Dr. Wolfinbarger is the Chief Scientific Officer at LifeNet Health and his work has resulted in dozens of patents. He received his B.S. from Kansas State College of Pittsburg in 1966, a M.S. and Ph.D. in molecular genetics from Florida State University in 1969 and 1972. He joined the Old Dominion University faculty of the Department of Biological Sciences after post doctoral study.

Founded in 1982 and headquartered in Virginia Beach, Virginia, LifeNet Health, Inc., is a leading biomedical alloengineering organization and organ and tissue donation agency whose mission is saving lives and restoring health. LifeNet Health provides recovery and processing services for musculoskeletal and cardiovascular tissues, distributing more than 250,000 biomedical implants every year to restore health to patients around the world.

For more information about LifeNet Health then visit http://www.lifenethealth.org.


'/>"/>
SOURCE LifeNet Health
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. LifeNet Health and IMS Announce Partnership
2. LifeNet Health and LOPA Announce a Partnership
3. LifeNet Health Saves 303 Lives and Restores Health to 265,967 Patients in 2007
4. LifeNet Health(R) Unveils New Biomedical Spine Implant
5. ETEX and LifeNet Health, Inc. Enter Agreement
6. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
7. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
8. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
9. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
10. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
11. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... and GREENWICH, Conn. , ... investment firm focused on venture growth investments in ... of Josh Richardson , M.D. to Managing ... in biotechnology companies.  He is a board observer ... roles in Longitude,s investments in Aimmune Therapeutics, Akebia ...
(Date:2/16/2017)... 16, 2017  ArmaGen, Inc., a privately held ... treat severe neurological disorders, today reported preliminary evidence ... the company,s investigational therapy for the treatment of ... type I, or MPS I). The initial results ... presented today at the 13 th annual ...
(Date:2/16/2017)... 2017   Capricor Therapeutics, Inc. (NASDAQ: ... developing first-in-class biological therapies for cardiac and other ... to terminate its license agreement with the Mayo ... Cenderitide. "Our decision to return these ... our efforts to advance our core cell and ...
(Date:2/16/2017)... , February 16, 2017 ... the infusion of innovative telemedicine application, new and ... that are experiencing a boom worldwide. The healthcare ... advancement of technologies, services and new therapies for ... RQHTF) (TSX-V: RHT), Cellectar Biosciences, Inc. (NASDAQ: ...
Breaking Biology Technology:
(Date:2/8/2017)... YORK , Feb. 7, 2017 Report Highlights ... The ... should reach $11.4 billion by 2021, growing at a compound ... Includes - An overview of the global markets for synthetic ... 2015, estimates for 2016, and projections of compound annual growth ...
(Date:2/7/2017)... 2017 Ipsidy Inc. ( www.ipsidy.com ... IDGS], ("Ipsidy" or the "Company") a provider of secure, ... is pleased to announce the following changes as part ... January 31, 2017, Philip D. Beck was ... President.  An experienced payment industry professional and public company ...
(Date:2/2/2017)... -- EyeLock LLC, a market leader of iris-based identity authentication ... You Should Know About Biometrics in the Cloud ."  ... a growing concern. In traditional schemes, cryptography is used ... schemes such as username/password suffer from inherent weaknesses. ... elegant solution to the problem of high-security user authentication. ...
Breaking Biology News(10 mins):